Reviews 9
Filters:
Rating
Language
Sort:
Most recent
C
7 months ago

Aravive, inc is a company worth mentioning. Their ...

Aravive, inc is a company worth mentioning. Their services are exceptional and I am highly satisfied with their performance. The team is dedicated, and their products are of the highest quality. I have recommended Aravive to my colleagues and they have all had positive experiences as well. I would definitely rate Aravive as excellent.

L
8 months ago

I recently came across Aravive, inc and I am extre...

I recently came across Aravive, inc and I am extremely impressed with their services. The team is highly professional and always goes the extra mile to ensure customer satisfaction. I have been using their products for the past few months and I must say they are of top-notch quality. The website is user-friendly and easy to navigate. Overall, I would rate Aravive, inc as excellent.

U
9 months ago

I have been a customer of this company for quite s...

I have been a customer of this company for quite some time now and I must say that I am impressed. Their products are reliable and their customer service is top-notch. I have never faced any issues while dealing with Aravive and their team has always been prompt in resolving any queries or concerns. Highly recommended!

O
11 months ago

Aravive, inc provides excellent services. Their pr...

Aravive, inc provides excellent services. Their products are of superior quality and their team is highly professional. I have been using their services for a while now and I am extremely satisfied. The website is easy to use and the overall experience has been great. I would rate Aravive as excellent.

C
1 year ago

As a satisfied customer of the company, I can conf...

As a satisfied customer of the company, I can confidently say that Aravive provides exceptional services. Their products are reliable and meet my requirements perfectly. The team is responsive and helpful, answering all my queries promptly. I highly recommend Aravive for anyone looking for a great company to work with.

T
1 year ago

👍 Aravive, inc is simply amazing! Their products a...

👍 Aravive, inc is simply amazing! Their products are top-notch and their customer service is fantastic. I have been using their services for a while now and I couldn't be happier. Keep up the great work! 👏

S
1 year ago

👌 Aravive, inc is absolutely amazing! Their produc...

👌 Aravive, inc is absolutely amazing! Their products are top-notch and their customer service is outstanding. I have recommended them to my friends and they have all had positive experiences. Keep up the good work! 💯

M
1 year ago

I am extremely happy with the services provided by...

I am extremely happy with the services provided by Aravive, inc. Their products are great and the team is highly responsive. I have never faced any issues and all my queries have been answered promptly. I would definitely recommend them to others.

About Aravive, inc.

Aravive, Inc. is a biopharmaceutical company that focuses on developing innovative therapies for the treatment of cancer and other diseases. The company's mission is to improve the lives of patients by providing them with effective and safe treatments that target specific molecular pathways involved in disease progression.

Aravive, Inc. was founded in 2015 by a team of experienced scientists and entrepreneurs who shared a common vision of using cutting-edge technologies to develop novel therapeutics for cancer and other diseases. Since its inception, the company has made significant progress in advancing its pipeline of drug candidates through preclinical and clinical development.

One of Aravive's most promising drug candidates is AVB-500, a first-in-class decoy protein that targets GAS6-AXL signaling pathway, which plays a critical role in promoting tumor growth and metastasis. AVB-500 has shown promising results in preclinical studies as well as early-stage clinical trials for various types of solid tumors.

In addition to AVB-500, Aravive is also developing other drug candidates targeting different molecular pathways involved in cancer progression. These include ARV-110, an oral small molecule inhibitor targeting the androgen receptor pathway for the treatment of prostate cancer; ARV-471, an oral small molecule inhibitor targeting estrogen receptor alpha (ERα) degradation for the treatment of breast cancer; and ARV-1906, an intravenous small molecule inhibitor targeting c-MET signaling pathway for the treatment of solid tumors.

Aravive's approach to drug development is based on deep understanding of disease biology combined with state-of-the-art technologies such as high-throughput screening assays, structural biology analysis, computational modeling, and biomarker discovery. The company collaborates with leading academic institutions as well as pharmaceutical companies to accelerate its research programs.

Aravive's management team consists of seasoned executives with extensive experience in biotech industry including Dr. Gail McIntyre (CEO), Dr. Ray Tabibiazar (CFO), and Dr. Reshma Rangwala (CMO). The company is headquartered in Houston, Texas, with additional offices in California and Switzerland.

Aravive's innovative approach to drug development has attracted significant attention from investors and the scientific community. The company has raised over $100 million in funding from leading venture capital firms such as Canaan Partners, 5AM Ventures, and OrbiMed Advisors. Aravive has also received several awards and recognitions for its groundbreaking research including the Frost & Sullivan 2020 North American Technology Innovation Award for Best Practices in Precision Oncology.

In conclusion, Aravive, Inc. is a biopharmaceutical company that is dedicated to developing innovative therapies for cancer and other diseases using cutting-edge technologies and deep understanding of disease biology. With a promising pipeline of drug candidates targeting specific molecular pathways involved in disease progression, Aravive is poised to make a significant impact on the field of oncology and improve the lives of patients worldwide.

Aravive, inc.

Aravive, inc.

4.4